Skip to main content
. 2013 Mar 8;8(3):e57720. doi: 10.1371/journal.pone.0057720

Table 3. Detailed outcomes of each the published studies included in the meta-analysis.

Source Persons Cohort (n) Classification of CVD No. of CVD RR (95% CI) of CVD Comparison The highest vs. lowest categories* Factors Controlled for in Multivariate Analysis
Dietary Magnesium Intake
Ascherio(1998) Male 43,738 Stroke 328 0.92 (0.58, 1.46) Quintile(V vs. I) 452 vs. 243 (median) Age, total intake of energy, potassium and fiber, smoking, alcohol consumption, history of hypertension, hypercholesterolemia, parental history of myocardial infarction, profession, BMI and PA.
Liao(1998) Male Female 6155 7767 CHD 223 96 0.69 (0.45, 1.0)1.32 (0.68, 2.5) Quartile(IV vs. I) Range: 39.9–485.1 Age, race, ARIC field center, smoking status, cigarette-years, alcohol drinking, PA, education level, fibrinogen, total cholesterol, HDL-C, triglycerides, WHR, diuretic use status, hormone replacement, SBP and diabetes status
Iso(1999) Female 85,764 Stroke 690 0.80 (0.63, 1.01) Quintile(V vs. I) 381 vs. 211 (median) Age and smoking status.
Abbott(2003) Male 7172 CHD 1431 0.59(0.40,0.91) Quintile(V vs. I) 340–1138 vs. 50.3–186 Age, BMI, the confounding dietary variable(s), total cholesterol, hypertension, diabetes, PA, smoking status, and alcohol intake.
Al-Delaimy (2004) Male 39,633 CHD 1449 0.82 (0.65, 1.05) Quintile(V vs. I) 453 vs. 261 (median) Age, BMI, time period, energy intake, history of diabetes, history of high cholesterol, smoking status, aspirin intake, family history of MI, vitamin E, alcohol, PA, and nutrient variables (trans fatty acid, total protein, cereal fiber, folate, omega 3 fatty acid, potassium).
Song(2005) Female 39,876 Total CVD events 1037 1.00 (0.82–1.23) Quintile(V vs. I) 433 vs. 255 (median) Age, BMI, randomized treatment assignment, total energy, smoking, PA, alcohol, multivitamin use, postmenopausal hormone use, history of diabetes, hypertension, hypercholesterolemia, and MI.
Larsson(2008) Male 26,556 Stroke 3281 0.87(0.77,0.97) Quintile(V vs. I) 575 vs. 382 (median) Age, BMI, supplementation group, smoking, BP, serum total cholesterol, serum HDL-C, histories of diabetes and CHD,PA, alcohol, and total energy.
Weng(2008) Female/Male 1772 Stroke 132 0.68 (0.45, 1.04) Quartile(IV vs. I) >282.2 vs. <242.6 Age, sex, smoking, area, central obesity, BMI, diabetes mellitus, physical activity, hypertension, use of antihypertensive drug, self-report heart disease, apolipoprotein B, hypercholesterolemia, hypertriglyceridemia, fibrinogen, plasminogen and alcohol intake
Ohira(2009) Male/Female 14,221 Stroke 557 0.80 (0.75, 1.13) Quartile(IV vs. I) >367 vs. <186 Age, BMI, sex, race-field center, smoking, LDL-C, HDL-C, fibrinogen, vWf, education. SBP, antihypertensive medication, and diabetes.
Kaluza(2010) Male 23,366 CVD death 819 1.25 (0.96, 1.61) Thirds(III v I) ≧481 vs. <426 Age, marital, education, self-reported health status, smoking status, PA, WHR, dietary fiber, saturated fatty acid, phosphorus, alcohol, vitamin D, calcium and intake.
Chiuve(2011) Female 88,375 CVD death 505 0.66 (0.46, 0.95) Quartile(IV vs. I) 383 vs. 235 (median) Age, BMI, history of CVD, total calories, smoking, parental history of myocardial infarction, alcohol, PA, use of aspirin, postmenopausal hormones, diuretics, calcium, potassium, and vitamin D, hypertension, diabetes, and hypercholesterolemia.
Larsson(2011) Female 34,670 Stroke 1680 0.92 (0.80, 1.07) Quintile(V vs. I) 373 vs. 267 (median) Age, smoking status, pack-years of smoking, educational, BMI, PA, history of diabetes and hypertension, aspirin use, family history of MI, and intakes of total energy, alcohol, protein, cholesterol, total fiber, and folate.
Zhang(2012) Male Female 23,083 35,532 CVD death 1343 1347 1.02 (0.85, 1.22)0.82 (0.69, 0.97) Quintile(V vs. I) 294 vs. 173 (median)274 vs. 175 (median) BMI, smoking status, ethanol intake, history of hypertension, history of diabetes, sports time, walking time, educational status and perceived mental stress, and for women, menopausal status and hormone replacement therapy.
Serum Magnesium Concentrations
Gartside (1995) Female/Male 8251 Total CVD events 492 0.68 (0.54,0.87) Thirds(III v I) ≧1.74 vs. <1.62 Age, sex, quetelet index, PA, exercise, sedimentation rate, dietary iron, smoking, maximum weight, alcohol, and riboflavin.
Liao(1998) Male Female 6155 7767 CHD 223 96 0.84 (0.53,1.31) 0.55 (0.27, 1.14) Quartile(IV vs. I) ≧1.8 vs. ≦1.5 Age, race, ARIC field center, smoking status, cigarette-years, alcohol drinking, PA, education, fibrinogen, total cholesterol, HDL-C, triglycerides, WHR, diuretic use status, hormone replacement, SBP and diabetes status.
Ford(1999) Female/Male 12,340 CHD CVD death 2637 1005 0.92 (0.79, 1.07) 0.69 (0.52, 0.90) Quartile(IV vs. I) ≧1.77 vs. <1.59 Age, sex, race, education, smoking status, cholesterol, SBP, diabetes, antihypertensive medication, BMI, PA, and alcohol consumption.
Leone(2006) Male 4035 CVD death 56 0.6 (0.2–1.2) Thirds(III v I) Range: 0.477–3.538 Age, BMI, smoking status, alcohol consumption, PA, LDL, HDL, cholesterol, triglycerides, diabetes, and CVD history.
Ohira(2009) Male/Female 14,221 Stroke 557 1.04 (0.82, 1.32) Quartile(IV vs. I) ≧1.8 vs. ≦1.5 Age, BMI, sex, race-field center, smoking, LDL-C, HDL-C, fibrinogen, vWf, education. SBP, antihypertensive medication, and diabetes.
Khan (2010) Male/Female 3531 Total CVD events 554 0.91 (0.72, 1.17) Quartile(IV vs. I) NA Age, sex, BMI, diabetes, SBP, smoking status, hypertension treatment, glomerular filtration rate hemoglobin, serum albumin, and total/HDL ratio.
Peacock(2010) Male/Female 14,232 CVD death 264 0.62 (0.42–0.93) Quartile(IV vs. I) ≧1.75 vs. ≦1.5 Age, race, sex, field center, HDL, LDL, TG, serum K, heart rate- adjusted QT interval, PA, smoking, pack-years, ETOH intake, education, diabetes, hypertension, and diuretics use.
Reffelmann (2011) Male/Female 3910 CVD death NA 0.60(0.41,0.88) Intergroup difference NA Age, sex, diabetes, smoking status, BMI, glomerular filtration rate, arterial hypertension, use of calcium antagonists, beta blocker, diuretics, statins, and ACE and angiotensin-receptor inhibitors.

BMI = body mass index; HDL-C = high density lipoprotein cholesterol; LDL-C = low density lipoprotein cholesterol; MI = myocardial infarction; PA = physical activity; SBP = systolic blood pressure; WHR = waist/hip ratio.

*

Mg/d for dietary magnesium intake and mEq/L for serum magnesium concentrations.

Recalculate from primal studies.